Letter to the editor: Unexpected high mortality in COVID-19 and diabetic ketoacidosis.
作者信息
Chamorro-Pareja Natalia, Parthasarathy Sahana, Annam Jayabhargav, Hoffman Julie, Coyle Christine, Kishore Preeti
机构信息
Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States of America.
Division of Infectious Diseases, Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States of America.
出版信息
Metabolism. 2020 Sep;110:154301. doi: 10.1016/j.metabol.2020.154301. Epub 2020 Jun 24.
Abstract
摘要
相似文献
1
Letter to the editor: Unexpected high mortality in COVID-19 and diabetic ketoacidosis.致编辑的信：2019冠状病毒病和糖尿病酮症酸中毒患者意外的高死亡率
Metabolism. 2020 Sep;110:154301. doi: 10.1016/j.metabol.2020.154301. Epub 2020 Jun 24.
2
Reply to comments on Letter to the Editor - Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.对《致编辑的信——1例新诊断糖尿病患者由新型冠状病毒肺炎引发的糖尿病酮症酸中毒》评论的回复
Diabetes Res Clin Pract. 2020 Aug;166:108305. doi: 10.1016/j.diabres.2020.108305. Epub 2020 Jul 3.
3
Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.与 COVID-19 相关的合并糖尿病酮症酸中毒和高渗高血糖状态患者的临床特征和结局：一项回顾性、基于医院的观察性病例系列研究。
Diabetes Res Clin Pract. 2020 Aug;166:108279. doi: 10.1016/j.diabres.2020.108279. Epub 2020 Jun 25.
4
Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection.致编辑的信：2型糖尿病合并新冠病毒感染患者的空腹血糖与死亡率的关系
Metabolism. 2020 Jul;108:154255. doi: 10.1016/j.metabol.2020.154255. Epub 2020 Apr 29.
5
Letter to the Editor: Two Perspectives on the COVID-19 Pandemic Nobody Is Talking About-and It's Costing Lives.致编辑的信：关于新冠疫情的两种未被提及的观点——且这正危及生命。
World Neurosurg. 2020 Jul;139:723. doi: 10.1016/j.wneu.2020.05.004. Epub 2020 May 18.
6
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.新型冠状病毒肺炎合并糖尿病酮症酸中毒：特殊关注点与注意事项
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa360.
7
Denominator matters in estimating COVID-19 mortality rates.在估算新冠病毒病死亡率时，分母很重要。
Eur Heart J. 2020 Oct 1;41(37):3500. doi: 10.1093/eurheartj/ehaa282.
8
SARS-CoV-2 viral load predicts COVID-19 mortality.严重急性呼吸综合征冠状病毒2型病毒载量可预测新冠肺炎死亡率。
Lancet Respir Med. 2020 Sep;8(9):e70. doi: 10.1016/S2213-2600(20)30354-4. Epub 2020 Aug 6.
9
The battle against COVID-19: mortality in Italy.抗击新冠疫情：意大利的死亡率
Eur Heart J. 2020 Jun 7;41(22):2050-2052. doi: 10.1093/eurheartj/ehaa326.
10
Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care.在瑞典一组危重症COVID-19患者中，抗SARS-CoV-2抗体反应较弱与死亡率相关。
Crit Care. 2020 Nov 6;24(1):639. doi: 10.1186/s13054-020-03362-y.
引用本文的文献
1
Inflammatory biomarkers predict higher risk of hyperglycemic crises but not outcomes in diabetic patients with COVID-19.炎症生物标志物可预测 COVID-19 合并糖尿病患者发生高血糖危象的风险更高，但不能预测结局。
Front Endocrinol (Lausanne). 2024 Feb 15;15:1287795. doi: 10.3389/fendo.2024.1287795. eCollection 2024.
2
Clinical profile and outcome of critically ill COVID-19 patients with diabetic ketoacidosis: A single-centre cross-sectional study in South India.患有糖尿病酮症酸中毒的重症 COVID-19 患者的临床特征与结局：印度南部的一项单中心横断面研究。
Indian J Anaesth. 2023 Mar;67(3):309-313. doi: 10.4103/ija.ija_368_22. Epub 2023 Mar 16.
3
Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review.COVID-19患者中急性胰腺炎（AP）合并糖尿病酮症酸中毒（DKA）的相关风险：文献综述
J Diabetes Metab Disord. 2023 Apr 8;22(1):135-146. doi: 10.1007/s40200-023-01207-3. eCollection 2023 Jun.
4
COVID-19 Related Predisposition to Diabetic Ketoacidosis.COVID-19相关的糖尿病酮症酸中毒易感性。
Cureus. 2023 Mar 25;15(3):e36674. doi: 10.7759/cureus.36674. eCollection 2023 Mar.
5
Insulin Requirements for Patients With COVID-19 Presenting With Diabetic Ketoacidosis.新冠病毒疾病合并糖尿病酮症酸中毒患者的胰岛素需求
Cureus. 2023 Jan 2;15(1):e33258. doi: 10.7759/cureus.33258. eCollection 2023 Jan.
6
Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies.病例报告：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染引发糖尿病酮症酸中毒及新检测出的胰腺自身抗体
Front Endocrinol (Lausanne). 2022 Aug 10;13:983206. doi: 10.3389/fendo.2022.983206. eCollection 2022.
7
Clinical Profile and Outcomes of Diabetic Ketoacidosis during the COVID-19 Pandemic in North India.印度北部新冠疫情期间糖尿病酮症酸中毒的临床特征和结局。
Trop Doct. 2022 Jul;52(3):375-381. doi: 10.1177/00494755221076896. Epub 2022 Mar 18.
8
The impact of COVID-19 on Diabetic Ketoacidosis patients.COVID-19 对糖尿病酮症酸中毒患者的影响。
Diabetes Metab Syndr. 2022 Jan;16(1):102389. doi: 10.1016/j.dsx.2022.102389. Epub 2022 Jan 7.
9
Diabetic ketoacidosis and high mortality among patients with coronavirus disease 2019 in a Peruvian hospital.秘鲁一家医院中2019冠状病毒病患者的糖尿病酮症酸中毒及高死亡率
J Diabetes Investig. 2022 Apr;13(4):746-748. doi: 10.1111/jdi.13704. Epub 2021 Nov 23.
10
Diabetic ketoacidosis and COVID-19: what have we learned so far?糖尿病酮症酸中毒与 COVID-19：目前我们了解多少？
Am J Physiol Endocrinol Metab. 2022 Jan 1;322(1):E44-E53. doi: 10.1152/ajpendo.00244.2021. Epub 2021 Nov 15.
本文引用的文献
1
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.在纽约布朗克斯的 COVID-19 患者队列中，严重肥胖、年龄增长和男性性别与住院期间的不良结局独立相关，并与更高的住院死亡率相关。
Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16.
2
Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs.纽约市各行政区的 COVID-19 住院和死亡情况存在差异。
JAMA. 2020 Jun 2;323(21):2192-2195. doi: 10.1001/jama.2020.7197.
3
Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.评论：2019冠状病毒病与糖尿病：我们所了解的情况、目前应如何治疗我们的患者以及接下来会发生什么。
Metabolism. 2020 Jun;107:154245. doi: 10.1016/j.metabol.2020.154245. Epub 2020 Apr 19.
4
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
5
COVID-19 infection may cause ketosis and ketoacidosis.COVID-19 感染可能导致酮症和酮酸中毒。
Diabetes Obes Metab. 2020 Oct;22(10):1935-1941. doi: 10.1111/dom.14057. Epub 2020 May 18.
6
The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities.COVID-19 大流行：呼吁采取行动，以确定和解决种族和族裔差异。
J Racial Ethn Health Disparities. 2020 Jun;7(3):398-402. doi: 10.1007/s40615-020-00756-0. Epub 2020 Apr 18.
7
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
8
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.致编辑的信：糖尿病患者中的 COVID-19：增加发病率的风险因素。
Metabolism. 2020 Jul;108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7.
9
COVID-19 pandemic, coronaviruses, and diabetes mellitus.COVID-19 大流行、冠状病毒和糖尿病。
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741. doi: 10.1152/ajpendo.00124.2020. Epub 2020 Mar 31.
10
Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.在中国武汉，新冠肺炎糖尿病患者需要更好的血糖管理。
Metabolism. 2020 Jun;107:154216. doi: 10.1016/j.metabol.2020.154216. Epub 2020 Mar 24.
Zotero 插件